2seventy bio, Inc.
TSVT
$4.99
$0.010.20%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -57.25M | -94.55M | -156.25M | -223.22M | -217.57M |
| Total Depreciation and Amortization | 7.10M | 8.47M | 9.58M | 10.14M | 10.29M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -37.85M | -35.85M | -17.79M | 35.97M | 37.82M |
| Change in Net Operating Assets | 3.00M | -17.19M | 14.34M | 17.47M | 2.60M |
| Cash from Operations | -85.00M | -139.12M | -150.13M | -159.65M | -166.86M |
| Capital Expenditure | -707.00K | -1.78M | -4.49M | -8.40M | -13.87M |
| Sale of Property, Plant, and Equipment | 43.18M | 43.18M | 43.18M | 176.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 38.29M | 65.27M | 125.53M | 29.12M | 57.73M |
| Cash from Investing | 80.76M | 106.66M | 164.22M | 20.90M | 43.86M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 441.00K | 691.00K | 639.00K | 767.00K | 127.47M |
| Repurchase of Common Stock | -24.00K | -24.00K | -99.00K | -75.00K | -75.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 417.00K | 667.00K | 540.00K | 692.00K | 127.39M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.82M | -31.79M | 14.63M | -138.06M | 4.39M |